Concentra Q2 Revenue Climbs 10% to $606M, Net Income Surges 46%
CON sits 65% above its 52-week low of $18.545.
Summary
Concentra posted strong Q2 2026 results featuring double-digit revenue and earnings growth, ongoing share buybacks, and a healthy balance sheet.
Key Events · Earnings and Guidance · CON
-
Q2 Revenue Up 10%
Revenue reached $606 million, driven by a 2.6% increase in patient visits and a 4.6% rise in revenue per visit, with both workers' compensation and employer services contributing.
-
Net Income Surges 46%
Net income attributable to the company was $65.3 million, or $0.51 per share, compared to $44.6 million, or $0.35 per share, in Q2 2025, reflecting improved operating leverage.
-
Share Repurchases Continue
The company bought back 1.1 million shares for $25.9 million in the first half of 2026, with $54.1 million remaining under its $100 million authorization.
-
Dividend Maintained
A quarterly dividend of $0.0625 per share was declared, payable on August 28, 2026, consistent with prior quarters.
Analysis · CON · Industrial Applications And Services
A standout second quarter saw revenue climb 10% to $606 million and net income surge 46% to $67.3 million, fueled by organic growth in patient visits and higher reimbursement rates, plus a lift from the Pivot Onsite Innovations acquisition. Shareholders benefited as well, with $25.9 million in stock repurchased during the first half and a regular quarterly dividend declared. The balance sheet remains a source of strength—leverage sits at just 2.99x against a 6.5x covenant. Importantly, the filing confirms no material changes in risk factors or internal controls, underscoring the company's operational stability.
How filings like this one have moved
In the 30 days to Aug 24, 2026, 37.5% of the 3362 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CON was trading at $30.54 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $3.9B. The 52-week trading range was $18.55 to $32.86. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.